According to the most recent financial data from March 2026, the current EPS (TTM) is $23.64. Elevance Health's EPS for 2025 came in at $25.28, marking a decrease from $25.81 in 2024. For the quarterly period ending on Mar 31, 2026, ELV's EPS was $8.03.
Elevance Health had an annual EPS of $25.28, marking a decrease of 2.1% from $25.81 in 2024. The quarterly EPS for the period ending Mar 31, 2026, was $8.03, marking a 16.7% decrease from the same quarter last year. ELV's TTM EPS stands at $23.64 as of March 2026. Elevance Health's EPS for 2024 stood at $25.81, a 1.7% increase from 2023.
Over the last 12 months, Elevance Health has registered an EPS growth of -16.7% (YoY, quarterly). Looking at a longer timeframe, the company recorded an average EPS growth rate of 1% per year over the past 3 years. Over the last 5 years, the company had an average EPS growth rate of 6.8%. A 10-year view shows that ELV has seen an average EPS growth of 10% per year.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| PFG Principal Financial Group Inc | 14.88 | -21.4% | -34.5% | 0.9% |
| ELV Elevance Health Inc | 17.58 | -2.1% | 1% | 6.8% |
| OSCR Oscar Health Inc | N/A | -1,636.4% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.